BioForce Nanosciences Holdings, Inc. Share Price
Equities
BFNH
US09064C2061
Other Specialty Retailers
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.63 USD | +12.41% | -6.32% | -18.91% |
Sales 2022 | - | Sales 2023 | - | Capitalization | 58.84M 4.69B |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | - 0 | EV / Sales 2022 | - |
Net Debt 2022 | 173K 13.83M | Net Debt 2023 | 220K 17.55M | EV / Sales 2023 | - |
P/E ratio 2022 |
-120
x | P/E ratio 2023 |
-101
x | Employees | 3 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 14.4% |
1 day | +12.41% | ||
1 week | -6.32% | ||
Current month | -4.12% | ||
1 month | -4.12% | ||
3 months | -12.83% | ||
6 months | -31.80% | ||
Current year | -18.91% |
Managers | Title | Age | Since |
---|---|---|---|
Steven Gagnon
CEO | Chief Executive Officer | 62 | 29/11/21 |
John LaViolette
CEO | Chief Executive Officer | 62 | 29/11/21 |
Sasha Shapiro
PSD | President | 61 | 29/11/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Merle Ferguson
CHM | Chairman | 76 | 07/07/13 |
Richard Kaiser
DFI | Director of Finance/CFO | 59 | 30/06/13 |
Date | Price | Change | Volume |
---|---|---|---|
25/04/24 | 1.63 | +12.41% | 39,028 |
23/04/24 | 1.45 | 0.00% | 8,100 |
Delayed Quote OTC Markets, April 25, 2024 at 05:03 pm
More quotes1st Jan change | Capi. | |
---|---|---|
-18.91% | 47.71M | |
-.--% | 843M | |
-0.79% | 657M | |
+5.50% | 384M | |
+23.83% | 229M | |
0.00% | 141M | |
+117.39% | 65.28M |
- Stock Market
- Equities
- BFNH Stock